2008
DOI: 10.1016/j.bbrc.2008.09.087
|View full text |Cite
|
Sign up to set email alerts
|

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
136
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(140 citation statements)
references
References 32 publications
3
136
1
Order By: Relevance
“…Interestingly, PD184352 had no effect on NGF-and PC-induced cytoprotection (data not shown), suggesting that ERK1/2 pathway did not mediate this effect. Next, we used BIX02188 or BIX02189, two recently identified specific inhibitors against MEK5, to investigate the potential involvement of ERK5 pathway (Tatake et al 2008). Both BIX02188 and BIX02189 completely blocked the protection against H 2 O 2 by NGF (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Interestingly, PD184352 had no effect on NGF-and PC-induced cytoprotection (data not shown), suggesting that ERK1/2 pathway did not mediate this effect. Next, we used BIX02188 or BIX02189, two recently identified specific inhibitors against MEK5, to investigate the potential involvement of ERK5 pathway (Tatake et al 2008). Both BIX02188 and BIX02189 completely blocked the protection against H 2 O 2 by NGF (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, the physiological functions of ERK5 in the CNS and peripheral nervous system (PNS) has been poorly studied, presumably due to the lack of selective pharmacological inhibitor(s), until the recently reported BIX02188 and BIX02189 compounds (Tatake et al 2008). Further, the technical challenge of delivering interfering molecules (i.e., siRNAs) efficiently into neurons has also been only more recently addressed.…”
Section: Discussionmentioning
confidence: 99%
“…Judging from these results, we used U0126 as a selective inhibitor for ERK1/2 signaling in this study. Recently, BIX02188 and BIX 02189 were developed as selective pharmacological inhibitors of the MEK5/ERK5 pathway (36). PC12 cells were pretreated with or without BIX02188 and BIX02189 (3-30 M) for 30 min, and the cells were stimulated with NGF (100 ng/ml) for 5 min.…”
Section: Ngf But Not Camp Induces Erk5 Phosphorylation In Pc12mentioning
confidence: 99%
“…Osmotic pump (Alzet 1007D) was from Durect Corporation (Cupertino, CA). MEK5 inhibitor BIX02188 was kindly provided by Boehringer Ingelheim Pharmaceuticals (Ridgefield, CT) (23). STAT5 inhibitor (NЈ-((4-oxo-4H-chromen-3-yl)methylene) nicotinohydrazide) (24) was from EMD Millipore (Billerica, MA).…”
Section: Methodsmentioning
confidence: 99%